228 related articles for article (PubMed ID: 24889007)
1. Does therapeutic intervention in atopic dermatitis normalize epidermal Notch deficiency?
Melnik BC
Exp Dermatol; 2014 Oct; 23(10):696-700. PubMed ID: 24889007
[TBL] [Abstract][Full Text] [Related]
2. The potential role of impaired Notch signalling in atopic dermatitis.
Melnik BC
Acta Derm Venereol; 2015 Jan; 95(1):5-11. PubMed ID: 24853951
[TBL] [Abstract][Full Text] [Related]
3. Current Understanding of Pathophysiological Mechanisms of Atopic Dermatitis: Interactions among Skin Barrier Dysfunction, Immune Abnormalities and Pruritus.
Fujii M
Biol Pharm Bull; 2020; 43(1):12-19. PubMed ID: 31902917
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular mechanisms in atopic dermatitis.
Oyoshi MK; He R; Kumar L; Yoon J; Geha RS
Adv Immunol; 2009; 102():135-226. PubMed ID: 19477321
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for itch and disease severity in atopic dermatitis.
Lee CH; Yu HS
Curr Probl Dermatol; 2011; 41():136-148. PubMed ID: 21576954
[TBL] [Abstract][Full Text] [Related]
6. Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology.
Melnik BC; Plewig G
Exp Dermatol; 2013 Mar; 22(3):172-7. PubMed ID: 23489419
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-33 in atopic dermatitis.
Imai Y
J Dermatol Sci; 2019 Oct; 96(1):2-7. PubMed ID: 31455506
[TBL] [Abstract][Full Text] [Related]
8. Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis.
Sano Y; Masuda K; Tamagawa-Mineoka R; Matsunaka H; Murakami Y; Yamashita R; Morita E; Katoh N
Clin Exp Immunol; 2013 Mar; 171(3):330-7. PubMed ID: 23379440
[TBL] [Abstract][Full Text] [Related]
9. Atopic dermatitis-like pruritic skin inflammation caused by feeding a special diet to HR-1 hairless mice.
Fujii M; Tomozawa J; Mizutani N; Nabe T; Danno K; Kohno S
Exp Dermatol; 2005 Jun; 14(6):460-8. PubMed ID: 15885082
[TBL] [Abstract][Full Text] [Related]
10. Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice.
Moosbrugger-Martinz V; Tripp CH; Clausen BE; Schmuth M; Dubrac S
J Cell Mol Med; 2016 May; 20(5):930-8. PubMed ID: 26931745
[TBL] [Abstract][Full Text] [Related]
11. Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway.
Lou H; Lu J; Choi EB; Oh MH; Jeong M; Barmettler S; Zhu Z; Zheng T
J Immunol; 2017 Apr; 198(7):2543-2555. PubMed ID: 28228560
[TBL] [Abstract][Full Text] [Related]
12. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
[TBL] [Abstract][Full Text] [Related]
14. Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Kim CH; Choi YS; Cheong KA; Lee AY
Int Immunopharmacol; 2013 Feb; 15(2):424-32. PubMed ID: 23352844
[TBL] [Abstract][Full Text] [Related]
15. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.
Furue M; Chiba T; Tsuji G; Ulzii D; Kido-Nakahara M; Nakahara T; Kadono T
Allergol Int; 2017 Jul; 66(3):398-403. PubMed ID: 28057434
[TBL] [Abstract][Full Text] [Related]
16. Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin.
Dumortier A; Durham AD; Di Piazza M; Vauclair S; Koch U; Ferrand G; Ferrero I; Demehri S; Song LL; Farr AG; Leonard WJ; Kopan R; Miele L; Hohl D; Finke D; Radtke F
PLoS One; 2010 Feb; 5(2):e9258. PubMed ID: 20174635
[TBL] [Abstract][Full Text] [Related]
17. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
[TBL] [Abstract][Full Text] [Related]
18. The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis.
Otsuka A; Nomura T; Rerknimitr P; Seidel JA; Honda T; Kabashima K
Immunol Rev; 2017 Jul; 278(1):246-262. PubMed ID: 28658541
[TBL] [Abstract][Full Text] [Related]
19. Immunization with a Pneumococcal pep27 Mutant Strain Alleviates Atopic Dermatitis through the Upregulation of Regulatory T-Cell Activity and Epithelial Barrier Function and Suppressing TSLP Expression.
Kim JH; Ahn S; Ghosh P; Rhee DK
J Invest Dermatol; 2023 Jan; 143(1):115-123.e6. PubMed ID: 35988588
[TBL] [Abstract][Full Text] [Related]
20. Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis.
Yang G; Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
